» Articles » PMID: 38595218

Outcomes of Patients with Preoperative Thrombocytosis After Hip Fracture Surgery

Overview
Specialty Orthopedics
Date 2024 Apr 10
PMID 38595218
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Low platelet counts have clinically relevant effects on patient outcomes after hip fracture surgery; however, the relationship between abnormally high platelet counts and postoperative outcomes in this population is unknown.

Methods: The ACS-NSQIP database was queried for patients who underwent hip fracture surgery between 2015 and 2019. Outcomes were compared between patients with normal platelet counts (150,000 to 450,000/μL) and thrombocytosis (>450,000/μL).

Results: Eighty-six thousand three hundred eleven hip fracture patients were identified, of which 1067 (1.2%) had preoperative thrombocytosis. Compared with patients with normal platelet counts, patients with preoperative thrombocytosis had increased rates of 30-day mortality (6.4% vs 4.5%, P = 0.004; OR 1.15 [95% CI 0.88 to 1.50], P = 0.322) as well as increased rates and odds of readmission (11.4% vs 7.8%, P < 0.001; OR 1.35 [95% CI 1.10 to 1.65], P = 0.004) and venous thromboembolic events (3.2% vs 1.7%, P < 0.001; OR 1.88 [95% CI 1.31 to 2.71], P < 0.001).

Conclusions: Hip fracture patients with preoperative thrombocytosis had increased rates of early mortality as well as increased odds of venous thromboembolic events and readmission. A patient with thrombocytosis may benefit from close postoperative surveillance and careful follow-up. Future prospective studies are needed to verify causation and investigate how to mitigate adverse outcomes in hip fracture patients with preoperative thrombocytosis.

References
1.
Malpani R, Bovonratwet P, Clark M, Ottesen T, Mercier M, Grauer J . Preoperative High, as well as Low, Platelet Counts Correlate With Adverse Outcomes After Elective Total Hip Arthroplasty. J Am Acad Orthop Surg Glob Res Rev. 2020; 4(9):e20.00049. PMC: 7470002. DOI: 10.5435/JAAOSGlobal-D-20-00049. View

2.
Duff O, Ho K, Maybury S . In vitro thrombotic tendency of reactive thrombocytosis in critically ill patients: a prospective case-control study. Anaesth Intensive Care. 2012; 40(3):472-8. DOI: 10.1177/0310057X1204000313. View

3.
Ho K, Yip C, Duff O . Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost. 2012; 10(9):1768-74. DOI: 10.1111/j.1538-7836.2012.04846.x. View

4.
Tchebiner J, Nutman A, Boursi B, Shlomai A, Sella T, Wasserman A . Diagnostic and prognostic value of thrombocytosis in admitted medical patients. Am J Med Sci. 2011; 342(5):395-401. DOI: 10.1097/MAJ.0b013e318214768d. View

5.
Smith B, Boswell M, Matzek L, Smith M . Thrombocytosis: Perioperative Considerations for Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019; 34(3):772-781. DOI: 10.1053/j.jvca.2019.07.131. View